easiest way to understand cryptocurrency, Knowledge graph

Tianma technology Group's Gao 'an Jianfeng Base caught fish. The reporter learned that recently, the eel in Jiangxi Gao 'an Jianfeng Smart Ecological Breeding Base of tianma technology Group (referred to as "Gao 'an Jianfeng Base") ushered in a bumper harvest.Market News: Apple CEO Cook will meet with US President-elect Trump on Friday local time.It is difficult to "choose a base" for the people in thousands of miles. How to solve the problem of consignment agencies, Public Offering of Fund's development is marching forward, and 10,000 funds compete on the same stage. Since the beginning of this year, the scale and quantity of Public Offering of Fund have hit record highs, and investors are also facing the "one in a million" difficulty in choosing a base. As a key link to solve this problem, the agency is speeding up its exploration. In the interview, the reporter learned that with the continuous strengthening of supervision and the continuous promotion of Public Offering of Fund's rate reform, the consignment agencies that have accelerated the reshuffle in the industry competition are deeply impressed by the traditional seller's sales thinking, and have explored the road of differentiated and characteristic services and accelerated the transformation to the buyer's investment mode. However, at present, the buyer's investment model in China is still in the early stage of development, and there are shortcomings such as low investor acceptance and insufficient technical allocation of institutional talents. The transformation of consignment agencies still has a long way to go and needs further refined development. (Securities Daily)

American polls show that half of Americans lack confidence in Trump's ability to nominate qualified cabinet members. A recent poll by the Associated Press -NORC Public Affairs Research Center shows that half of Americans lack confidence in President-elect Trump's ability to nominate qualified people for the new cabinet or key administrative positions. According to the survey results, 55% of American respondents have "a little confidence" or "no confidence at all" in Trump's ability to select qualified candidates during his second term, and another 27% have "very confidence". The poll was conducted from December 5 to 9, and the respondents were 1251 American adults, with a margin of error of 3.7 percentage points. (CCTV)Shanghai Stock Exchange: This week, the coastal market has a surplus of transportation capacity, and the comprehensive index is under pressure. According to Shanghai Stock Exchange, this week, the downstream demand is sluggish, the terminal purchasing enthusiasm is not high, and due to multiple factors such as the recovery of ship turnover and the return of concurrently operated ships, the market transportation capacity is surplus, and the comprehensive index is slightly lower. On December 13th, the China coastal (bulk) comprehensive freight index released by Shanghai Shipping Exchange closed at 1123.01 points, down 1.7% from the previous period.USGS: A 6.4-magnitude earthquake occurred 41km southeast of Molina, Chile.

Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times)Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times)Yu Baozhong, former member of the Party Committee and inspector of the Guangdong Provincial Department of Justice, accepted the disciplinary review and supervision investigation. According to the news of the Guangdong Provincial Commission for Discipline Inspection, Yu Baozhong, former member of the Party Committee and inspector of the Guangdong Provincial Department of Justice, was suspected of serious violation of the law and is currently under disciplinary review and supervision investigation by the Guangdong Provincial Commission for Discipline Inspection.